Trial intelligence / Profile preview

Humalog vs Insulin Aspart in Type 1 Diabetes Pump Users

NCT01134107Phase 3Completed

Sponsor
Eli Lilly and Company
Start
Nov 2010
Primary completion
Dec 2011
Modality
Recombinant Proteins and Enzymes
Countries
3
01

Overview

A Phase 3 trial of human insulin in type 1 diabetes mellitus (T1D), sponsored by Eli Lilly and Company. Started Nov 2010; status: completed.

02

Drugs

human insulin
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT01134107.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01134107.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call